Abstract: A memory device includes a floating gate, a control gate, a spacer structure, a dielectric layer, and an erase gate. The floating gate is above a substrate. The floating gate has a curved sidewall. The control gate is above the floating gate. The spacer structure is in contact with the control gate and the floating gate. The spacer structure is spaced apart from the curved sidewall of the floating gate. The dielectric layer is in contact with the spacer structure and the curved sidewall of the floating gate. The erase gate is above the dielectric layer.

Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.

Abstract: A touch display device including a drive chip and a touch display panel is provided. The drive chip includes a first common voltage source and a second common voltage source. The touch display panel includes a plurality of touch electrode including a plurality of rows and columns, wherein the number of columns is odd-numbered. The touch display panel includes a middle column, a first region and a second region. The middle column is interposed between the first region and the second region having the same number of touch electrodes. The touch electrodes in the first region and that in the second region are coupled to the first common voltage source and the second common voltage source respectively. The middle column is divided into a first half and a second half by a reference line. The first half and the second half have the same number of touch electrodes.

Abstract: An intraoral scanner includes a device body and a connection portion. The device body has a heat-dissipating structure and a first electrical connection port. The connection portion is detachably connected to the device body and includes a second electrical connection port and a fan. The second electrical connection port is electrically connected to the first electrical connection port. The fan generates an airflow that flows through the heat-dissipating structure.

Abstract: An optical module includes a base, a first optical component and at least two washers. The first optical component is disposed on the base and the first optical component has a flange. The washers are disposed on the first optical component and sandwiched in between the base and the flange. Each of the washers has a first side surface and a second side surface, wherein the first side surface and the second side surface tilt with respect to each other by an angle.

Abstract: The present invention is directed to a depot composition for sustained release delivery of buprenorphine with enhanced stability and bioavailability. The composition is an injectable, low viscosity liquid and can form a depot in situ capable of delivering therapeutic level of buprenorphine over a period of time from one week to 3 months.

Abstract: A semiconductor device includes: a fin structure disposed on a substrate; a gate feature that traverses the fin structure to overlay a central portion of the fin structure; a pair of source/drain features, along the fin structure, that are disposed at respective sides of the gate feature; and a plurality of contact structures that are formed of tungsten, wherein a gate electrode of the gate feature and the pair of source/drain features are each directly coupled to a respective one of the plurality of contact structures.

Abstract: An optical module includes a housing, an optical component, a first elastic member and a second elastic member. The housing has a first end, a second end and a through hole, wherein the first end is opposite to the second end. The optical component is disposed in the through hole. The optical component has a third end and a fourth end, wherein the third end is opposite to the fourth end, the third end protrudes from the first end, and the fourth end protrudes from the second end. The first elastic member is rotatably disposed on the first end and abuts against the third end. The second elastic member is rotatably disposed on the second end and abuts against the fourth end.

Abstract: A touch display device including a drive chip and a touch display panel is provided. The drive chip includes a first common voltage source and a second common voltage source. The touch display panel includes a plurality of touch electrode including a plurality of rows and columns, wherein the number of columns is odd-numbered. The touch display panel includes a middle column, a first region and a second region. The middle column is interposed between the first region and the second region having the same number of touch electrodes. The touch electrodes in the first region and that in the second region are coupled to the first common voltage source and the second common voltage source respectively. The middle column is divided into a first half and a second half by a reference line. The first half and the second half have the same number of touch electrodes.

Abstract: A balance mechanism comprises a working device, a connecting arm assembly having a variable length, a torque-balancing assembly, a weighting member, and a connecting member. The connecting arm assembly couples to the working device. The connecting arm assembly is pivoted to the torque-balancing assembly by a pivot. The weighting member couples to the torque-balancing assembly. The connecting member connects the connecting arm assembly and the torque-balancing assembly. As the distance between the working device and the pivot changes, the distance between the weighting member and the pivot changes accordingly, so that a dynamic balance can be achieved.

Abstract: The present invention relates to a three-dimensional (3D) tissue-like implant for transplanting to a subject in need comprising a cell cluster comprising mesenchymal stem cells (MSCs) and specific cells differentiated therefrom. The present invention also relate to a method of preparing a 3D-tissue-like implant from MSCs, particularly by seeding MSCs in alginate scaffolds and culturing the alginate scaffolds with MSCs in a 3-D perfusion condition. Further, the present invention provides a method for treating a defect in a recipient patient in need by administering a 3D tissue-like implant as described herein to the patient at a defective site e.g. a bone defective site.

Abstract: A fan includes an impeller, a drive device, and a frame structure. The driving device drives the impeller to rotate, and the frame structure accommodates the driving device. The frame structure includes a frame body, a first frame, a second frame, a base and a plurality of supports. The frame body has first engaging portions and second engaging portions, which are disposed annularly at the upper end and the lower end of the frame body, respectively. The first frame is mounted on the frame body and disposed corresponding to the first engaging portions. The second frame is mounted on the frame body and disposed corresponding to the second engaging portions. The base is disposed within the frame body and located adjacent to the second frame. The supports are disposed around the base. The material of the frame body is different from that of the first and second frames.

Abstract: A semiconductor structure includes a substrate having a plurality of fin structures thereon, an isolation oxide structure in the substrate between adjacent two of the plurality of fin structures, a gate disposed on the plurality of fin structures, a gate dielectric layer disposed between the plurality of fin structures and the gate, and a source/drain doped region in each of the plurality of fin structures. The isolation oxide structure has a concave, curved top surface.

Abstract: A semiconductor device includes: a fin structure disposed on a substrate; a gate feature that traverses the fin structure to overlay a central portion of the fin structure; a pair of source/drain features, along the fin structure, that are disposed at respective sides of the gate feature; and a plurality of contact structures that are formed of tungsten, wherein a gate electrode of the gate feature and the pair of source/drain features are each directly coupled to a respective one of the plurality of contact structures.

Abstract: A method for forming a semiconductor device structure is provided. The method includes depositing a gate dielectric layer over a substrate. The substrate has a base portion and a first fin portion over the base portion, and the gate dielectric layer is over the first fin portion. The method includes forming a gate electrode layer over the gate dielectric layer. The gate electrode layer includes fluorine. The method includes annealing the gate electrode layer and the gate dielectric layer so that fluorine from the gate electrode layer diffuses into the gate dielectric layer.

Abstract: A method for establishing a computer-aided data interpretation model for immune diseases by immunomarkers and visualization is revealed. First combine a plurality of immunomarkers into an immunomarker panel. Then collect test data of a plurality of subjects measured by the immunomarker panel, and disease diagnosis information of the subjects for establishment of an immunomarker-panel testing database. Next new subjects are tested by the immunomarker panel. The data obtained and the corresponding information in the immunomarker-panel testing database are processed by unsupervised machine learning algorithm to get a computer-aided data interpretation model showing comparison of case distribution patterns. The method provides real-time analysis of multiple data to medical professionals for their reference. Thereby the correctness, the timeliness and the reproducibility of the interpretation result for the diagnosis and treatment of immune diseases are all improved.

Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.

Abstract: A semiconductor structure includes a substrate having a plurality of fin structures thereon, an isolation oxide structure in the substrate between adjacent two of the plurality of fin structures, a gate disposed on the plurality of fin structures, a gate dielectric layer disposed between the plurality of fin structures and the gate, and a source/drain doped region in each of the plurality of fin structures. The isolation oxide structure has a concave, curved top surface.

Abstract: An epitaxial process applying light illumination includes the following steps. A substrate is provided. A dry etching process and a wet etching process are performed to form a recess in the substrate, wherein an infrared light illuminates while the wet etching process is performed. An epitaxial structure is formed in the recess.

Abstract: A semiconductor structure includes a substrate having a plurality of fin structures thereon, an isolation oxide structure in the substrate between adjacent two of the plurality of fin structures, a gate disposed on the plurality of fin structures, a gate dielectric layer disposed between the plurality of fin structures and the gate, and a source/drain doped region in each of the plurality of fin structures. The isolation oxide structure has a concave, curved top surface.